Literature DB >> 30393377

eKLIPse: a sensitive tool for the detection and quantification of mitochondrial DNA deletions from next-generation sequencing data.

David Goudenège1,2, Celine Bris1,2, Virginie Hoffmann1, Valerie Desquiret-Dumas1,2, Claude Jardel3, Benoit Rucheton3, Sylvie Bannwarth4, Veronique Paquis-Flucklinger4, Anne Sophie Lebre5, Estelle Colin1,2, Patrizia Amati-Bonneau1,2, Dominique Bonneau1,2, Pascal Reynier1,2, Guy Lenaers1, Vincent Procaccio6,7.   

Abstract

PURPOSE: Accurate detection of mitochondrial DNA (mtDNA) alterations is essential for the diagnosis of mitochondrial diseases. The development of high-throughput sequencing technologies has enhanced the detection sensitivity of mtDNA pathogenic variants, but the detection of mtDNA rearrangements, especially multiple deletions, is still poorly processed. Here, we present eKLIPse, a sensitive and specific tool allowing the detection and quantification of large mtDNA rearrangements from single and paired-end sequencing data.
METHODS: The methodology was first validated using a set of simulated data to assess the detection sensitivity and specificity, and second with a series of sequencing data from mitochondrial disease patients carrying either single or multiple deletions, related to pathogenic variants in nuclear genes involved in mtDNA maintenance.
RESULTS: eKLIPse provides the precise breakpoint positions and the cumulated percentage of mtDNA rearrangements at a given gene location with a detection sensitivity lower than 0.5% mutant. eKLIPse software is available either as a script to be integrated in a bioinformatics pipeline, or as user-friendly graphical interface to visualize the results through a Circos representation ( https://github.com/dooguypapua/eKLIPse ).
CONCLUSION: Thus, eKLIPse represents a useful resource to study the causes and consequences of mtDNA rearrangements, for further genotype/phenotype correlations in mitochondrial disorders.

Entities:  

Keywords:  mitochondrial diseases; mitochondrial genome; mtDNA deletions; next-generation sequencing; soft clipping

Mesh:

Substances:

Year:  2018        PMID: 30393377     DOI: 10.1038/s41436-018-0350-8

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  15 in total

Review 1.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

2.  Long read mitochondrial genome sequencing using Cas9-guided adaptor ligation.

Authors:  Amy R Vandiver; Brittany Pielstick; Timothy Gilpatrick; Austin N Hoang; Hillary J Vernon; Jonathan Wanagat; Winston Timp
Journal:  Mitochondrion       Date:  2022-07-03       Impact factor: 4.534

3.  Cancer/Testis Antigen 55 is required for cancer cell proliferation and mitochondrial DNA maintenance.

Authors:  Jade Aurrière; David Goudenege; Simone A Baechler; Shar-Yin N Huang; Naig Gueguen; Valerie Desquiret-Dumas; Floris Chabrun; Rodolphe Perrot; Arnaud Chevrollier; Majida Charif; Olivier R Baris; Yves Pommier; Guy Lenaers; Salim Khiati
Journal:  Mitochondrion       Date:  2022-02-18       Impact factor: 4.534

Review 4.  Thinking outside the nucleus: Mitochondrial DNA copy number in health and disease.

Authors:  Christina A Castellani; Ryan J Longchamps; Jing Sun; Eliseo Guallar; Dan E Arking
Journal:  Mitochondrion       Date:  2020-06-13       Impact factor: 4.160

5.  Splice-Break: exploiting an RNA-seq splice junction algorithm to discover mitochondrial DNA deletion breakpoints and analyses of psychiatric disorders.

Authors:  Brooke E Hjelm; Brandi Rollins; Ling Morgan; Adolfo Sequeira; Firoza Mamdani; Filipe Pereira; Joana Damas; Michelle G Webb; Matthieu D Weber; Alan F Schatzberg; Jack D Barchas; Francis S Lee; Huda Akil; Stanley J Watson; Richard M Myers; Elizabeth C Chao; Virginia Kimonis; Peter M Thompson; William E Bunney; Marquis P Vawter
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

6.  Dominant mutations in mtDNA maintenance gene SSBP1 cause optic atrophy and foveopathy.

Authors:  Camille Piro-Mégy; Emmanuelle Sarzi; Aleix Tarrés-Solé; Marie Péquignot; Fenna Hensen; Mélanie Quilès; Gaël Manes; Arka Chakraborty; Audrey Sénéchal; Béatrice Bocquet; Chantal Cazevieille; Agathe Roubertie; Agnès Müller; Majida Charif; David Goudenège; Guy Lenaers; Helmut Wilhelm; Ulrich Kellner; Nicole Weisschuh; Bernd Wissinger; Xavier Zanlonghi; Christian Hamel; Johannes N Spelbrink; Maria Sola; Cécile Delettre
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

7.  Mitochondrial DNA deletion mutations increase exponentially with age in human skeletal muscle.

Authors:  Allen Herbst; Cathy C Lee; Amy R Vandiver; Judd M Aiken; Debbie McKenzie; Austin Hoang; David Allison; Nianjun Liu; Jonathan Wanagat
Journal:  Aging Clin Exp Res       Date:  2020-09-23       Impact factor: 4.481

8.  Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma.

Authors:  Amnani Aminuddin; Pei Yuen Ng; Chee-Onn Leong; Eng Wee Chua
Journal:  Sci Rep       Date:  2020-05-12       Impact factor: 4.379

9.  Genomic Landscape of the Mitochondrial Genome in the United Arab Emirates Native Population.

Authors:  Fatma A Aljasmi; Ranjit Vijayan; Naganeeswaran Sudalaimuthuasari; Abdul-Kader Souid; Noushad Karuvantevida; Raja Almaskari; Hidaya Mohammed Abdul Kader; Biduth Kundu; Khaled Michel Hazzouri; Khaled M A Amiri
Journal:  Genes (Basel)       Date:  2020-08-01       Impact factor: 4.096

10.  Mitochondrial genome variation in male LHON patients with the m.11778G > A mutation.

Authors:  Agnieszka Piotrowska-Nowak; Maciej R Krawczyński; Ewa Kosior-Jarecka; Anna M Ambroziak; Magdalena Korwin; Monika Ołdak; Katarzyna Tońska; Ewa Bartnik
Journal:  Metab Brain Dis       Date:  2020-08-01       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.